News
Click here for news in Danish.
May 12, 2021 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchApril 29, 2021 | Company Announcements
Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 VariantsApril 20, 2021 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held April 20, 2021April 17, 2021 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchApril 06, 2021 | Company Announcements
Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines March 29, 2021 | Company Announcements
Bavarian Nordic A/S – Notice Convening Ordinary General MeetingMarch 26, 2021 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseMarch 26, 2021 | Company Announcements
Bavarian Nordic Announces the Resignation of Tommi Kainu as EVP and Chief Business Officer March 22, 2021 | Company Announcements
Bavarian Nordic Receives Additional Smallpox Vaccine Order from the Canadian Government March 17, 2021 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.March 12, 2021 | Company Announcements
Bavarian Nordic A/S - Registration of Share Capital Increase of 5,150,000 New Shares CompletedMarch 12, 2021 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMarch 12, 2021 | Company Announcements
Bavarian Nordic Publishes Annual Report 2020 March 10, 2021 | Company Announcements
Bavarian Nordic A/S Announces Completion of Directed Issue and Private Placement of 5,150,000 New Ordinary SharesMarch 09, 2021 | Company Announcements
Bavarian Nordic A/S Seeks to Strengthen its Capital Base and Commits to Ambitious Strategy on Promising COVID-19 Vaccine CandidateMarch 09, 2021 | Company Announcements
Bavarian Nordic Reports 2021 Financial GuidanceMarch 08, 2021 | Company Announcements
Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human TrialJanuary 28, 2021 | Company Announcements
Bavarian Nordic Reports Preliminary Financial Results for 2020December 18, 2020 | Company Announcements
Bavarian Nordic Announces Top-line Results from Phase 2 Clinical Trial of BN-Brachyury in ChordomaDecember 16, 2020 | Company Announcements
Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. GovernmentDecember 08, 2020 | Company Announcements
Bavarian Nordic Introduces New Employee Incentive Program November 16, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.November 13, 2020 | Company Announcements
CORRECTION: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchNovember 11, 2020 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchNovember 11, 2020 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2020